Previous studies [28] have proposed that the hypercoagulability of blood may be more severe in patients with cirrhosis with poorer liver function because of their resistance to thrombomodulin activity, a critical factor mediating the anticoagulation process. The gene discussed is THBD; the disease is Cirrhosis.